Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1988
Incorporation of chlorpromazine into bilayer liposomes for protection against microsomal metabolism and liver absorptionR A SchwendenerCancer Drug Delivery|January 1, 1986
The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytostatic drugs by the use of a capillary dialyzerR A SchwendenerAnti-Cancer Drug Design|September 1, 1996
Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugatesH Schott, R A SchwendenerJournal of Cancer Research and Clinical Oncology|January 1, 1996
Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia modelR A Schwendener, H SchottInternational Journal of Cancer|May 28, 1992
Treatment of L1210 murine leukemia with liposome-incorporated N4-hexadecyl-1-beta-D-arabinofuranosyl cytosineR A Schwendener, H SchottInternational Journal of Cancer|September 15, 1989
Discrepancy in the abilities of lymphokines and bacteria to mediate tumor protection in vivo and/or tumoricidal activity by macrophages in vitroR Keller, R Keist, R A SchwendenerCancer Chemotherapy and Pharmacology|January 1, 1995
Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937D H Horber, H Schott, R A SchwendenerBritish Journal of Cancer|May 1, 1995
Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosineD H Horber, H Schott, R A SchwendenerJournal of Chromatography. B, Biomedical Applications|April 26, 1996
Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatographyK M Rentsch, R A Schwendener, E HänselerThe Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Interactions with human blood in vitro and pharmacokinetic properties in mice of liposomal N4-octadecyl-1-beta-D-arabinofuranosylcytosine, a new anticancer drugS K Koller-Lucae, H Schott, R A SchwendenerPageof 6